European Union

Travis Perkins: Transaction in Own Shares

Retrieved on: 
Monday, December 6, 2021
London Stock Exchange, European Union (Withdrawal) Act 2018, Article, Retained firefighter, London, The Company, Common stock, Treasury, Company, European Union, Security (finance)

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Travis Perkins plc (the "Company") announces that it has purchased the following number of its ordinary shares of 11.205105 pence each on the London Stock Exchange, from Citigroup Global Markets Limited as part of its buy-back programme announced on 21 September 2021:
    Number of Ordinary Shares Purchased:
    The repurchased shares will be held in treasury (and some may subsequently be transferred to the Company's employee benefit trust).
  • Following the purchase of these shares, Travis Perkins holds 2,685,335 of its ordinary shares in treasury and has 222,340,591 ordinary shares in issue (excluding treasury shares).

KBRA Assigns Preliminary Ratings to Harbour No.1 PLC

Retrieved on: 
Friday, December 3, 2021
Banking, Professional Services, Finance, Ontario Securities Commission, Saint Augustine House, Credit, European Union, European Securities and Markets Authority, ESG, Insurance commissioner, CRA, National Association, U.S. Securities and Exchange Commission, Prospectus, National Association of Insurance Commissioners, LLC, Union, KBRA, Jetivia SA v Bilta (UK) Limited (in liquidation), Security (finance)

This credit rating is endorsed by Kroll Bond Rating Agency Europe Limited for use in the European Union.

Key Points: 
  • This credit rating is endorsed by Kroll Bond Rating Agency Europe Limited for use in the European Union.
  • Information on a credit ratings endorsement status is available on its rating page at KBRA.com.
  • Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO.
  • KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider.

Transaction in Own Shares

Retrieved on: 
Friday, December 3, 2021
Withdrawal, Royal Dutch Shell, Listing Rules, European Union, Company, Market abuse, Union, European Union (Withdrawal) Act 2018, LEI, European Union (Withdrawal Agreement) Act 2020, Online gambling

These share purchases form part of the Company's share buy-back arrangement previously announced on 02 December 2021.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 02 December 2021.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 02 December 2021 up to and including 28 January 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • All other details of the announcement were correct
    LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70

ING reports outcome of 2021 EU-wide Transparency Exercise and Risk Assessment Report

Retrieved on: 
Friday, December 3, 2021
ING Group, Table, International, Biophysical environment, Risk, Turnaround ADR, Morning Star, European Union, STOXX, Social Security Government Pension Offset, Social, FTSE Russell, New, ESG, Annual report, CDP, Legislation, Lung compliance, FATCA, Climate change, United, Union, COVID-19, ING, S&P Global Ratings, Internet, Failure, Life, Risk management

ING is a global financial institution with a strong European base, offering banking services through its operating company ING Bank.

Key Points: 
  • ING is a global financial institution with a strong European base, offering banking services through its operating company ING Bank.
  • The purpose of ING Bank is empowering people to stay a step ahead in life and in business.
  • ING Group shares are listed on the exchanges of Amsterdam (INGA NA, INGA.AS), Brussels and on the New York Stock Exchange (ADRs: ING US, ING.N).
  • In January 2021, ING received an ESG evaluation score of 83 ('strong') from S&P Global Ratings.

Seating for Circularity: naughtone to Offer Sofa Designed With the End in Mind

Retrieved on: 
Friday, December 3, 2021
Herman Miller (manufacturer), European, European Union, Recycling, Solution, Plant, HAY, Creativity, Collection, Union, Brand management, Life, Rest, Furniture

When naughtone approached him to work on a brand-new collection of sustainable seating solutions inspired by naughtone's popular Always collection, it was a perfect match.

Key Points: 
  • When naughtone approached him to work on a brand-new collection of sustainable seating solutions inspired by naughtone's popular Always collection, it was a perfect match.
  • When he began the project with naughtone, Frampton started with the end in mind.
  • And customers won't need to worry about recycling it themselves after a sofa reaches the end of its life, the sofa can simply be returned to naughtone via the company's take-back program.
  • The Ever sofa marks the first upholstered product naughtone has intentionally designed for circularity and easily executable end of life recycling.

BEYOND Expo Macao opens today with these highlights not to be missed!

Retrieved on: 
Friday, December 3, 2021
TDB, Ministry of Commerce (Myanmar), Exhibition, Expo, Information technology, New Silk Road Initiative, Technology, Industry, European Union, Belt, Diagnosis, PTAC, Breast, Commerce, D, Laboratory, Ministry, City, Convention center, Research, Communication, Telecommunication, Electronics, Union, Friends, Science, Life, ICT, SAR, Travel, Joint, Intelligence, Video game, Consumer electronics, Film, Warehouse

BEIJING, Dec. 3, 2021 /PRNewswire/ -- The BEYOND International Technology Innovation Expo (BEYOND Expo) hosted by the Macao Technology General Association was opened at The Venetian Macao on December 2nd.

Key Points: 
  • BEIJING, Dec. 3, 2021 /PRNewswire/ -- The BEYOND International Technology Innovation Expo (BEYOND Expo) hosted by the Macao Technology General Association was opened at The Venetian Macao on December 2nd.
  • As a partner, the Trade Development Bureau of the Ministry of Commerce (TDB) organized mainland enterprises to participate in the expo.
  • The International Technology Innovation Expo (BEYOND EXPO) TDB Zone will be held at Venetian Macao Convention and Exhibition Centre on December 2nd -4th.
  • PTAC EXPO is the official organizer of the PT Expo China (PTEXPO), a well-known ICT industry event in China and in the Asia-Pacific region.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, December 3, 2021
United Arab Emirates, European Union, PARK, BioCryst Pharmaceuticals, Galidesivir, RESEARCH, Nasdaq, GLOBE, Yellow fever, United Kingdom, Union, Marburg virus disease, Employment, Disease, Pharmaceutical industry

The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
  • Each stock option has a 10-year term and is subject to the terms and conditions of BioCrysts Inducement Equity Incentive Plan and a stock option agreement covering the grant.
  • Oral, once-daily ORLADEYO (berotralstat) is approved in the United States, the European Union, Japan, the United Kingdom and the United Arab Emirates.
  • RAPIVAB (peramivir injection) has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea.

Travis Perkins: Transaction in Own Shares

Retrieved on: 
Friday, December 3, 2021
London Stock Exchange, European Union (Withdrawal) Act 2018, Article, Retained firefighter, London, The Company, Common stock, Treasury, Company, European Union, Security (finance)

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Travis Perkins plc (the "Company") announces that it has purchased the following number of its ordinary shares of 11.205105 pence each on the London Stock Exchange, from Citigroup Global Markets Limited as part of its buy-back programme announced on 21 September 2021:
    Number of Ordinary Shares Purchased:
    The repurchased shares will be held in treasury (and some may subsequently be transferred to the Company's employee benefit trust).
  • Following the purchase of these shares, Travis Perkins holds 2,685,112 of its ordinary shares in treasury and has 222,340,814 ordinary shares in issue (excluding treasury shares).

ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer

Retrieved on: 
Friday, December 3, 2021
Patient, Senior, Man, Docetaxel, Safety, Prostate cancer, Overalls, European Union, DASL, Diagnosis, Recurrence, Cancer, Radiation, Traffic barrier, SSE, Darolutamide, Congress, Central nervous system, Malignancy, Survival, ADT, Risk, Phase, Incidence, Marketing, Ari, Union, AES, Growth, Orion, II, CNS, Disease, CRPC, Medical imaging, Pharmaceutical industry

In the ARASENS trial, darolutamide in combination with docetaxel and androgen deprivation therapy (ADT) significantly increased overall survival (OS) compared to placebo, docetaxel and ADT.

Key Points: 
  • In the ARASENS trial, darolutamide in combination with docetaxel and androgen deprivation therapy (ADT) significantly increased overall survival (OS) compared to placebo, docetaxel and ADT.
  • The results show that darolutamide, a compound discovered by Orions scientists, in combination with docetaxel and androgen deprivation therapy improves overall survival for patients with metastatic hormone-sensitive prostate cancer.
  • Men with metastatic hormone-sensitive prostate cancer (mHSPC) will start their treatment with hormone therapy, such as ADT, androgen receptor inhibitor (ARi) plus ADT or a combination of the chemotherapy docetaxel and ADT.
  • Despite this treatment, most men with mHSPC will eventually progress to castration-resistant prostate cancer (CRPC), a condition with limited survival.

Transaction in Own Shares

Retrieved on: 
Thursday, December 2, 2021
Withdrawal, Royal Dutch Shell, Listing Rules, European Union, Company, Market abuse, Union, European Union (Withdrawal) Act 2018, European Union (Withdrawal Agreement) Act 2020, Animal, Online gambling

These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.
  • In respect of this arrangement, Exane BNP Paribas will make trading decisions in relation to the Companys securities independently of the Company for a period from 29 July 2021 up to and including 29 December 2021.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by Exane BNP Paribas on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70